Spirovant Sciences
PrivateLast Round
Grant
Jan 23, 2019
Total Funding Raised
$4.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Spirovant Sciences operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Grant round in January 2019.
Spirovant Sciences is a biotechnology company that develops gene therapies for cystic fibrosis and other respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spirovant Sciences Comparables
Compare Spirovant Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReCode Therapeutics | 87% | |
| cystetic Medicines | 83% | |
| 4DMT | 82% |
For institutional investors. Book with your work email.
Spirovant Sciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Spirovant Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emily's Entourage | Seed |
| Militia Hill Ventures | Seed |
| Cystic Fibrosis Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 336% MoM.
- Apr 1, 2026
Monthly visitors increased 63% MoM.
For institutional investors. Book with your work email.
Spirovant Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Spirovant Sciences's valuation, stock price, and market status.
Is Spirovant Sciences a public or private company?
Spirovant Sciences is a private company.
What is the current stock price of Spirovant Sciences?
Spirovant Sciences is a private company, so its shares have no public market price. Caplight tracks Spirovant Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Spirovant Sciences worth (valuation)?
Valuation information for Spirovant Sciences is not publicly available.
Can I buy Spirovant Sciences stock?
Spirovant Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Spirovant Sciences's last funding round?
Spirovant Sciences's most recent funding round was Grant on January 23, 2019.
Who are the main investors in Spirovant Sciences?
Key investors in Spirovant Sciences include Emily's Entourage, Cystic Fibrosis Foundation.
Will Spirovant Sciences IPO soon?
No public IPO plans have been announced for Spirovant Sciences.
How can I track Spirovant Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Spirovant Sciences's shares on secondary markets.